Why Arm Holdings Stock Jumped 39% in April

Arm Holdings shares jumped 39% last month as investors responded to its first-ever plan to build its own CPU, improving sentiment around AI-related CPU demand. Intel's stronger-than-expected Q1 results and commentary that demand is shifting back from GPUs to CPUs also helped lift the stock, alongside analyst price target hikes and a risk-on backdrop. Arm reports earnings Wednesday, with analysts expecting revenue of $1.47 billion, up 18.4%, and adjusted EPS of $0.58 versus $0.55 previously.

Analysis

ARM’s move is less about one quarter of fundamentals and more about a regime change in how investors value control of the CPU stack. If ARM can convert from a pure toll-collector into a silicon participant, the market will start assigning it a higher share of the AI value chain, but that also compresses the moat on its royalty model: customers may welcome the architecture while resisting any future attempt to capture more of the chip economics. The first-order winner is ARM sentiment; the second-order loser is likely the OEM/customer base if ARM’s in-house ambitions push licensing negotiations harder or encourage design-around behavior over the next 6-18 months.

Intel’s better execution matters less as a direct competitor to ARM than as a demand signal for the entire compute budget shifting toward CPUs after an overearnings period for accelerators. That is supportive for INTC and modestly supportive for NVDA only if data center expansion keeps growing faster than the CPU rebalancing; otherwise, CPU share gains can become a relative headwind for GPU multiples. AMD is the clearest potential underperformer in the near term because it sits in the middle: it competes in both CPU and data center narratives but lacks ARM’s IP leverage and Intel’s turnaround optionality, so it can get squeezed if investors rotate toward the perceived beneficiaries of inference-era compute.

The market is likely overrating the immediacy of ARM’s new monetization path. Any meaningful contribution from in-house silicon is years away, while the stock has already priced in an accelerated growth story; that leaves a setup where earnings or guidance only need to disappoint slightly for a sharp de-rating. The key risk is not that ARM’s thesis is wrong, but that the timeline is too long and the execution risk is too opaque for a multiple this elevated.

Near term, the best catalyst/risk window is the next 1-3 earnings prints: if ARM raises long-range commentary without near-term revenue evidence, the stock can still sell off on “show me” dynamics. If management signals partner pushback or capex intensity around the chip effort, the valuation premium could compress quickly. Conversely, continued CPU demand strength should keep the sector bid, but that likely supports a relative trade rather than a blanket long.

Key Decisions for Investors

• Use any post-earnings strength in ARM to fade into a 1-3 month horizon via a bearish risk-defined structure (e.g., put spread) — upside is increasingly narrative-driven, while downside on any guidance ambiguity could be 15-25%.
• Pair trade: long INTC / short AMD over 4-8 weeks — Intel has the cleaner near-term CPU demand rerating catalyst, while AMD is more vulnerable to multiple compression if the market narrows the winner set in AI compute.
• Maintain a tactical long ARM vs short a basket of software-infrastructure names exposed to licensing pressure only if ARM proves its silicon ambitions are non-disruptive; otherwise, keep position size small because the risk is strategic self-cannibalization.
• For event-driven accounts, buy NVDA on any broad AI tape weakness only on a 3-6 month horizon, not as a CPU rotation trade — the risk/reward improves if the market overreacts to CPU strength and misses continued data center capex growth.
• Set a near-term alert on ARM’s commentary around partner adoption and execution timeline; any hint of customer resistance is a high-conviction de-rating trigger within days, not months.